You are viewing the site in preview mode

Skip to main content

Advertisement

Figure 1 | BMC Health Services Research

Figure 1

From: The impact of generic-only drug benefits on patients' use of inhaled corticosteroids in a Medicare population with asthma

Figure 1

Adjusted mean monthly ICS days-of-supply (2003–2004) for lower-cost and higher-cost ICS users in 2003 by coverage group. Note: The graph presents the adjusted mean monthly days-of-supply (standardized to a 30-day month) of all inhaled corticosteroids for the Unrestricted and Restricted Coverage groups. Bars represent 95% confidence intervals.

Back to article page